149 related articles for article (PubMed ID: 7882348)
21. Mutational analysis of the CDKN2 (MTS1/p16ink4A) gene in primary B-cell lymphomas.
Uchida T; Watanabe T; Kinoshita T; Murate T; Saito H; Hotta T
Blood; 1995 Oct; 86(7):2724-31. PubMed ID: 7670111
[TBL] [Abstract][Full Text] [Related]
22. Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma.
Flores JF; Walker GJ; Glendening JM; Haluska FG; Castresana JS; Rubio MP; Pastorfide GC; Boyer LA; Kao WH; Bulyk ML; Barnhill RL; Hayward NK; Housman DE; Fountain JW
Cancer Res; 1996 Nov; 56(21):5023-32. PubMed ID: 8895759
[TBL] [Abstract][Full Text] [Related]
23. Homozygous codeletion and differential decreased expression of p15INK4b, p16INK4a-alpha and p16INK4a-beta in mouse lung tumor cells.
Herzog CR; Soloff EV; McDoniels AL; Tyson FL; Malkinson AM; Haugen-Strano A; Wiseman RW; Anderson MW; You M
Oncogene; 1996 Nov; 13(9):1885-91. PubMed ID: 8934534
[TBL] [Abstract][Full Text] [Related]
24. Deletion and mutation analyses of the P16/MTS-1 tumor suppressor gene in human ductal pancreatic cancer reveals a higher frequency of abnormalities in tumor-derived cell lines than in primary ductal adenocarcinomas.
Huang L; Goodrow TL; Zhang SY; Klein-Szanto AJ; Chang H; Ruggeri BA
Cancer Res; 1996 Mar; 56(5):1137-41. PubMed ID: 8640773
[TBL] [Abstract][Full Text] [Related]
25. Evidence for u.v. induction of CDKN2 mutations in melanoma cell lines.
Pollock PM; Yu F; Qiu L; Parsons PG; Hayward NK
Oncogene; 1995 Aug; 11(4):663-8. PubMed ID: 7651729
[TBL] [Abstract][Full Text] [Related]
26. Inactivation of the cyclin-dependent kinase inhibitor p15INK4b by deletion and de novo methylation with independence of p16INK4a alterations in murine primary T-cell lymphomas.
Malumbres M; Pérez de Castro I; Santos J; Meléndez B; Mangues R; Serrano M; Pellicer A; Fernández-Piqueras J
Oncogene; 1997 Mar; 14(11):1361-70. PubMed ID: 9178896
[TBL] [Abstract][Full Text] [Related]
27. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
Elisei R; Shiohara M; Koeffler HP; Fagin JA
Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724
[TBL] [Abstract][Full Text] [Related]
28. Inactivation of multiple tumor-suppressor genes involved in negative regulation of the cell cycle, MTS1/p16INK4A/CDKN2, MTS2/p15INK4B, p53, and Rb genes in primary lymphoid malignancies.
Hangaishi A; Ogawa S; Imamura N; Miyawaki S; Miura Y; Uike N; Shimazaki C; Emi N; Takeyama K; Hirosawa S; Kamada N; Kobayashi Y; Takemoto Y; Kitani T; Toyama K; Ohtake S; Yazaki Y; Ueda R; Hirai H
Blood; 1996 Jun; 87(12):4949-58. PubMed ID: 8652807
[TBL] [Abstract][Full Text] [Related]
29. FISH analysis of translocations involving the short arm of chromosome 9 in lymphoid malignancies.
Leblanc T; Derré J; Flexor M; Le Coniat M; Leroux D; Rimokh R; Larsen CJ; Berger R
Genes Chromosomes Cancer; 1997 Aug; 19(4):273-7. PubMed ID: 9258663
[TBL] [Abstract][Full Text] [Related]
30. Incidence and clinical significance of CDKN2/MTS1/P16ink4A and MTS2/P15ink4B gene deletions in childhood acute lymphoblastic leukemia.
Zhou M; Gu L; Yeager AM; Findley HW
Pediatr Hematol Oncol; 1997; 14(2):141-50. PubMed ID: 9089742
[TBL] [Abstract][Full Text] [Related]
31. Homozygous deletions of methylthioadenosine phosphorylase (MTAP) are more frequent than p16INK4A (CDKN2) homozygous deletions in primary non-small cell lung cancers (NSCLC).
Schmid M; Malicki D; Nobori T; Rosenbach MD; Campbell K; Carson DA; Carrera CJ
Oncogene; 1998 Nov; 17(20):2669-75. PubMed ID: 9840931
[TBL] [Abstract][Full Text] [Related]
32. [Tribulations of the p16/MTS1/CDKN2 tumor gene suppressor: a continuing saga].
Larsen CJ
Bull Cancer; 1997 Apr; 84(4):427-30. PubMed ID: 9238169
[TBL] [Abstract][Full Text] [Related]
33. Homozygous loss of the MTS1/p16 and MTS2/p15 genes in lymphoma and lymphoblastic leukaemia cell lines.
Siebert R; Willers CP; Schramm A; Fosså A; Dresen IM; Uppenkamp M; Nowrousian MR; Seeber S; Opalka B
Br J Haematol; 1995 Oct; 91(2):350-4. PubMed ID: 8547074
[TBL] [Abstract][Full Text] [Related]
34. Genomic DNA and messenger RNA expression alterations of the CDKN2B and CDKN2 genes in esophageal squamous carcinoma cell lines.
Zhou X; Suzuki H; Shimada Y; Imamura M; Yin J; Jiang HY; Tarmin L; Abraham JM; Meltzer SJ
Genes Chromosomes Cancer; 1995 Aug; 13(4):285-90. PubMed ID: 7547637
[TBL] [Abstract][Full Text] [Related]
35. Deletion mapping indicates that MTS1 is the target of frequent deletions at chromosome 9p21 in paediatric acute lymphoblastic leukaemias.
Guidal-Giroux C; Gérard B; Cavé H; Duval M; Rohrlich P; Elion J; Vilmer E; Grandchamp B
Br J Haematol; 1996 Feb; 92(2):410-9. PubMed ID: 8603008
[TBL] [Abstract][Full Text] [Related]
36. Absence of p15INK4B and p16INK4A gene alterations in primary cervical carcinoma tissues and cell lines with human papillomavirus infection.
Kim JW; Namkoong SE; Ryu SW; Kim HS; Shin JW; Lee JM; Kim DH; Kim IK
Gynecol Oncol; 1998 Jul; 70(1):75-9. PubMed ID: 9698478
[TBL] [Abstract][Full Text] [Related]
37. The prognostic significance of p16INK4a/p14ARF and p15INK4b deletions in adult acute lymphoblastic leukemia.
Faderl S; Kantarjian HM; Manshouri T; Chan CY; Pierce S; Hays KJ; Cortes J; Thomas D; Estrov Z; Albitar M
Clin Cancer Res; 1999 Jul; 5(7):1855-61. PubMed ID: 10430092
[TBL] [Abstract][Full Text] [Related]
38. Chromosome 9 related aberrations and deletions of the CDKN2 and MTS2 putative tumor suppressor genes in human chondrosarcomas.
Jagasia AA; Block JA; Qureshi A; Diaz MO; Nobori T; Gitelis S; Iyer AP
Cancer Lett; 1996 Jul; 105(1):91-103. PubMed ID: 8689637
[TBL] [Abstract][Full Text] [Related]
39. p16INK4A and p15INK4B gene deletions in primary leukemias.
Haidar MA; Cao XB; Manshouri T; Chan LL; Glassman A; Kantarjian HM; Keating MJ; Beran MS; Albitar M
Blood; 1995 Jul; 86(1):311-5. PubMed ID: 7795238
[TBL] [Abstract][Full Text] [Related]
40. Homozygous deletions of the p15 (MTS2) and p16 (CDKN2/MTS1) genes in adult T-cell leukemia.
Hatta Y; Hirama T; Miller CW; Yamada Y; Tomonaga M; Koeffler HP
Blood; 1995 May; 85(10):2699-704. PubMed ID: 7742529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
